A
Andes
Empowers microbes to enable positive action against climate change
About Andes
Andes, a biotechnology company established in 2018, is focused on developing microbial technology to address climate change through agricultural applications. Founded by CEO Gonzalo Fuenzalida and CTO Tania Timmermann, the company originated from Fuenzalida's background in investment banking and passion for nature, combined with insights from renowned scientists. Based in Alameda, California, Andes operates at the intersection of biology and climate tech.
Read full description
The company's business model centers on two primary technological platforms: nitrogen fixation and carbon dioxide removal. The first, a product called Microprime, involves treating seeds with beneficial microbes that colonize the plant's roots. This process enables crops, such as corn, to fix nitrogen from the atmosphere, thereby reducing the dependency on synthetic nitrogen fertilizers, which are a significant source of greenhouse gas emissions. The first generation of these treated seeds aims to provide the equivalent of 30 to 50 lbs/acre of nitrogen. This technology is designed for seamless integration into existing farming practices, allowing the specialized seeds to be stored and handled like conventional ones.
The second core area of business is a nature-based carbon capture solution. Andes has developed proprietary microorganisms that are added to the soil along with seeds for crops like corn, soybean, and wheat. These microbes grow with the plant roots and accelerate the conversion of atmospheric CO2 into stable minerals within the soil, a process called microbial carbon mineralization. This method provides a form of permanent carbon storage, sequestering CO2 for thousands of years. The company generates revenue by creating and selling validated carbon removal credits to organizations aiming to meet sustainability goals. For farmers, enrolling in the Andes Carbon Removal Program offers a new revenue stream, potentially increasing their net income by up to 25-30%, without requiring upfront investment.
Andes has successfully raised a total of $38 million in funding through multiple Series A rounds, with the latest in March 2023. Key investors include Leaps by Bayer, Cavallo Ventures, Voyager VC, and Yamaha Motor Ventures. The capital is being used to expand the commercialization of its technologies, increase partnerships with farmers across the U.S. Midwest, and further research and development. The technology has already been deployed across tens of thousands of acres, removing a reported 50,000 tonnes of CO2.
At a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Emeryville, United States
- Employees
- 225
- Open positions
- 1
- Dealroom signal
- 75.7/100
- Sub-industry
- AgriTech
- Sector
- Food, Predictive Analytics, Biotechnology, Pesticides, Microbiology, Core AI, Synthetic Biology, Spinout, Novel Farming
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Sep 2023
- Capital deployed
- $80M
- Preferred round
- SERIES D
Latest news
Press, funding announcements and product moves mentioning Andes.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2023 | $15M | $60M | Leaps by Bayer · Germin8 Ventures · Cavallo Ventures · KdT Ventures | ↗ |
| SERIES A✓Equity / VC | Sep 2021 | $15M | $60M | Wilson Sonsini · Germin8 Ventures · KdT Ventures · Leaps by Bayer | — |
Growth signals
Latest recorded traffic for Andes is 2.6K monthly website visits, down 10.3% over the last three months. Andes's team grew 4.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Blueprint FinanceLas Vegas, United StatesBlueprint Finance is a software development firm dedicated to constructing the future of on-chain finance
$38Mvaluation
DalCor PharmaceuticalsMontreal, CanadaPrecision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits
$500Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Fondo Alerce VC
KdT Ventures
Fen Ventures
Series A9 investors entered at this stage
Wilson Sonsini
Germin8 Ventures
Leaps by Bayer
ACCELR8
Builders VC
Cavallo Ventures
Yamaha Motor Ventures
Voyager VC
Venturance
Other known investors3 additional known investors
Adolfo Ibáñez University
Sahsen Ventures
Food System 6
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Andes on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Andes’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







